GFAP and Alzheimer disease: Although we showed the reduction in GFAP levels by CLOCK/BMAL1 over-expression in human astrocytes, there is a limitation to support whether the elevation of CLOCK/BMAL1 can directly affect the impairment of GFAP-mediated interaction of astrocytes in patients with AD.